Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project

Abstract Objectives To investigate the effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux. Design Cross sectional study, followed by a randomised placebo controlled trial. Setting Seven general practices in Bristol, England. Participants 10 537 people, aged 20-59 years, with and without H pylori infection (determined by the 13C-urea breath test). Main outcome measures Prevalence of heartburn and gastro-oesophageal acid reflux at baseline and two years after treatment to eradicate H pylori infection. Results At baseline, H pylori infection was associated with increased prevalence of heartburn (odds ratio 1.14, 95% confidence interval 1.05 to 1.23) but not reflux (1.05, 0.97 to 1.14). In participants with H pylori infection, active treatment had no effect on the overall prevalence of heartburn (0.99, 0.88 to 1.12) or reflux (1.04, 0.91 to 1.19) and did not improve pre-existing symptoms of heartburn or reflux. Conclusions H pylori infection is associated with a slightly increased prevalence of heartburn but not reflux. Treatment to eradicate H pylori has no net benefit in patients with heartburn or gastro-oesophageal reflux.

[1]  P. Malfertheiner,et al.  Risk Factors for Erosive Esophagitis: A Multivariate Analysis Based on the ProGERD Study Initiative , 2004, The American Journal of Gastroenterology.

[2]  O. B. Schaffalitzky de Muckadell,et al.  Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population. , 2003, Gastroenterology.

[3]  L. Laine,et al.  Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies , 2002, American Journal of Gastroenterology.

[4]  J. Donovan,et al.  A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: study design and response rates of the Bristol Helicobacter Project. , 2002, Controlled clinical trials.

[5]  Justin C.Y. Wu,et al.  Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis , 2002, Alimentary pharmacology & therapeutics.

[6]  A. Axon,et al.  Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. , 2001, Gastroenterology.

[7]  G. Manes,et al.  High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[8]  S. V. Zanten.  Treatment of Helicobacter pylori infection unmasks rather than induces symptoms of gastro-oesophageal reflux disease. , 2001 .

[9]  C. Mcnulty,et al.  The significance of cagA + Helicobacter pylori in reflux oesophagitis , 2001, Gut.

[10]  Y. Yamaji,et al.  Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects , 2001, Gut.

[11]  J. Dent,et al.  Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial , 2001, The Lancet.

[12]  T. Koike,et al.  Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis , 2001, Alimentary pharmacology & therapeutics.

[13]  C. Morran,et al.  A beneficial effect of H. pylori eradication in reflux patients in the community , 2001 .

[14]  G. Lindberg,et al.  Curing Helicobacter pylori Infection in Patients with Duodenal Ulcer Does Not Provoke Gastroesophageal Reflux Disease , 2000, Helicobacter.

[15]  E. Kuipers,et al.  Colonization with cagA-Positive Helicobacter pylori Strains Inversely Associated with Reflux Esophagitis and Barrett’s Esophagus , 2000, Digestion.

[16]  Kamada,et al.  High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis , 2000, Alimentary pharmacology & therapeutics.

[17]  J. Mason,et al.  Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial , 2000, The Lancet.

[18]  A. Barkun,et al.  Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases , 2000, American Journal of Gastroenterology.

[19]  K. Haruma,et al.  Negative Association Between Helicobacter pylori Infection and Reflux Esophagitis in Older Patients: Case‐Control Study in Japan , 2000, Helicobacter.

[20]  R. Cherian,et al.  Prospective evaluation of the prevalence of gastric helicobacter pylori infection in patients with GERD, barrett's esophagus, barrett's dysplasia, and barrett's adenocarcinoma , 2000, American Journal of Gastroenterology.

[21]  T. Koike,et al.  Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylorieradication , 2000, Gut.

[22]  T. Shimosegawa,et al.  Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis , 1999, American Journal of Gastroenterology.

[23]  O. Kawamura,et al.  Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings , 1999, Journal of Gastroenterology.

[24]  A. Sonnenberg,et al.  Corpus gastritis is protective against reflux oesophagitis , 1999, Gut.

[25]  G. Fantry,et al.  Decreased Prevalence of Helicobacter pylori Infection in Gastroesophageal Reflux Disease , 1998, Helicobacter.

[26]  E. El-Omar,et al.  Helicobacter pylori infection and chronic gastric acid hyposecretion. , 1997, Gastroenterology.

[27]  A. Blum,et al.  Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. , 1997, Gastroenterology.

[28]  P. Malfertheiner,et al.  A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. , 1997, Gut.

[29]  E. El-Omar,et al.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. , 1995, Gastroenterology.

[30]  P. Sipponen,et al.  Morphology and dynamics of the gastric mucosa in duodenal ulcer patients and their first-degree relatives. , 1983, Hepato-gastroenterology.

[31]  R. Loffeld,et al.  Helicobacter pylori Infection Has No Role in the Pathogenesis of Reflux Esophagitis , 2004, Digestive Diseases and Sciences.

[32]  S. Veldhuyzen van Zanten.  Treatment of Helicobacter pylori infection unmasks rather than induces symptoms of gastro-oesophageal reflux disease. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[33]  J. C. M. Frcp,et al.  Clinicians’ Guide to Helicobacter pylori , 1996, Springer US.